Os Therapies announced it raised $3.78 Million in an initial filing from an offering of $3.78 Million
PUBLIC · OSTXSep 10, 2025
Amount Raised
$3.78 Million
Round Type
Venture
New YorkBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma
Company Information
Company
Os Therapies
Location
New York, New York, United States
About
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.
Fundz sees it the moment Os Therapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.